Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

Abroad (travel likely)RecruitingPHASE2

Conditions

Type II Diabetes Mellitus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Lynn Institute of the Ozarks, Little Rock, Arkansas, United States

  • Family First Medical Research Center, Hialeah Gardens, Florida, United States

  • Alliance for Multispecialty Research (AMR Clinical) - Wichita East, Lakeland, Florida, United States

  • CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis), Lakeland, Florida, United States

  • GTL Medical & Research Group, Miami, Florida, United States

  • Florida Institute for Clinical Research LLC, Orlando, Florida, United States

  • AMR Clinical, El Dorado, El Dorado, Kansas, United States

  • AMR Clinical - Newton, Newton, Kansas, United States

  • Lynn Health Science Institute - Oklahoma City, Oklahoma City, Oklahoma, United States

  • Endolife Specialty Hospitals Pvt. Ltd., Guntur, Andhra Pradesh, India

  • Life Care Hospital and Research Centre, Bangalore, Karnataka, India

  • Government Medical College, Kozhikode, Kerala, India

  • Jothydevs Diabetes Research Centre, Trivandrum, Kerala, India

  • Nirmal Hospital Private Limited, Kolhāpur, Maharashtra, India

  • Topiwala National Medical College & BYL Nair Hospital, Mumbai, Maharashtra, India

  • Seth G. S. medical college and KEM hospital, Mumbai, Maharashtra, India

  • BSES Municipal General Hospital, Mumbai, Maharashtra, India

  • LMMF's Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India

  • Lady Hardinge Medical College and S.S.K. Hospital, New Delhi, National Capital Territory of Delhi, India

  • All India Institute of Medical Sciences, New Delhi, National Capital Territory of Delhi, India

  • Madras Diabetes Research Foundation (MDRF), Chennai, Tamil Nadu, India